Lukey, M. J., Cluntun, A. A., Katt, W. P., Lin, M. J., Druso, J. E., Ramachandran, S., . . . Cerione, R. A. (2019). Liver-Type Glutaminase GLS2 Is a Druggable Metabolic Node in Luminal-Subtype Breast Cancer. Cell Rep.
シカゴスタイル引用形Lukey, Michael J., et al. "Liver-Type Glutaminase GLS2 Is a Druggable Metabolic Node in Luminal-Subtype Breast Cancer." Cell Rep 2019.
MLA引用形式Lukey, Michael J., et al. "Liver-Type Glutaminase GLS2 Is a Druggable Metabolic Node in Luminal-Subtype Breast Cancer." Cell Rep 2019.
警告: この引用は必ずしも正確ではありません.